Spero Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of SPRO for the last quarter is 71.83 M USD, and it's 207.19% higher compared to the previous quarter. The net income of Q4 23 is 51.19 M USD.